Omnicell stockholders elect three directors and approve 1.6 million added plan shares
At its May 19, 2026 annual meeting, Omnicell stockholders elected Joanne B. Bauer, Robin G. Seim and Eileen J. Voynick as Class I directors and approved an amendment adding 1,600,000 shares to the 2009 Equity Incentive Plan. They also approved a charter amendment, filed May 20, 2026, that provides officer exculpation from personal liability as permitted by Delaware law, and ratified Deloitte & Touche LLP as auditor for 2026. The share increase expands the number of shares available for issuance under the plan.
Key points
- Bauer, Seim and Voynick elected to serve until the 2029 Annual Meeting of Stockholders
- Equity plan amendment approved: 35,182,712 for, 1,472,716 against, 100,392 abstain, 4,704,566 broker non-votes
- Charter amendment approved: 34,320,796 for, 2,419,140 against, 15,884 abstain; filed with Delaware on May 20, 2026
- Deloitte & Touche LLP ratified for the year ending December 31, 2026: 41,224,274 for, 206,940 against
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:55 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 26, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.